Order early for Christmas

Helapet will be closed between Christmas and the New Year. Please make sure that you order enough stock to cover for this period.

Our offices will re-open for business on 4th January 2011

Great results from our customer survey

Thank you to all of you who took the time to complete our customer service questionnaire and a delicious Christmas hamper is on it's way to Claire in Kettering who has won the prize draw.

We are proud that 86% of our customers are very satisfied with Helapet overall and 86% of you would refer us to a colleague.

Our survey highlights that we are more responsive than our competitors, ordering is easy and the quality of our products is excellent.

As a result of your replies, we will be making improvements to our customer service, with a restructure to our website to include more educational downloads and technical support.

Thank you for helping us improve our service to you

New paper free pouch for Berner Gloves

Berner remains the glove of choice for those handling cytotoxics within an aseptic environment and the new upgrade to poly packaging enables them to be used in paper free environments.

Berner gloves are CE marked and aseptically presented in a clean peel pouch printed with lot number and expiry date and the poly pouches can be liberally sprayed with alcohol for aseptic transfer.

The gloves fully comply with European PPE category III, EN374 chemical and bacteriological and EN388 mechanical standards. Full breakthrough data for a range of cytotoxics including carmustine, cisplastin and methotrexate together with other technical support information is available on request.

For more information on how to safely manage cytotoxic substances in your department, please call Helapet on 0800 0328 428, or visit our website on www.helapet.co.uk to view our full range.

Rowespike vent excellent choice for reconstitution

When a needle or spike is inserted into a vial, hazardous aerosols can be released that are both harmful to operators and can cross contaminate other products in the aseptic area or isolator cabinet.

The NEW Rowespike Vent will protect operators and avoid cross contamination and is an ideal choice for reconstituting cytotoxics.

New Rowespike Vent with metal cannula is easy to use for repeated withdrawal and aspiration of cytostatic solutions from vials, bottles and bags.

The metal cannula avoids needlestick injury and will easily pierce bungs and bags for sterile venting purposes and your syringe will conveniently secure directly to the top of the device using the luer lock.

Rowespike vent has a 0.1 micron PTFE hydrophobic bacteria filter for effective sterile venting of cytotoxic and other hazardous aerosols. The vents are ETO sterilised and supplied individually sterile wrapped in packs of 150 pieces with full lot traceability.

http://www.helapet.com/acatalog/Sterile_Venting_Devices.html

Call 0800 0328 428

Helapet launch new filter devices website

We are pleased to introduce our upgraded filtration website and catalogue showcasing our range of standard and custom made filter devices.

Helapet filtration devices primarily serve the medical, printing, laboratory, gas, and air markets, providing compact and robust filters for a diverse number of applications.

Take a look on www.filterdevices.co.uk

New series 4 study day programme

We are pleased to announce our new series 4 study day programme: mAbs preparation of monoclonal antibodies, practical aspects and risk management.

The first study day will be held on 16th December 2010 at Nutfield priory in Redhill, Surrey, with guest speakers, Tim Sizer, Mark Oldcorne, Maria Connolly and Julie Simpson.

The day is aimed at pharmacists and senior technicians with more details to be found at www.helapet.net

Helapet staff raise money for Macmillan

A fun coffee morning was held at Helapet offices on 24th September to join in the world's biggest coffee morning for Macmillan.
Staff brought in delicious home made goodies and made a contribution to sample the fare. A fantastic £54.10 was raised for Macmillan cancer research.